Verona Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Verona Pharma and buy or sell other stocks, ETFs, and their options commission-free!About VRNA
Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. It focuses on developing inhaled ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease.
CEOBenjamin Lucas
CEOBenjamin Lucas
Employees209
Employees209
HeadquartersLondon, Greater London
HeadquartersLondon, Greater London
Founded2005
Founded2005
Employees209
Employees209
VRNA Key Statistics
Market cap9.19B
Market cap9.19B
Price-Earnings ratio-103.78
Price-Earnings ratio-103.78
Dividend yield—
Dividend yield—
Average volume384.22K
Average volume384.22K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$106.93
52 Week high$106.93
52 Week low$31.60
52 Week low$31.60
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.